Trials / Terminated
TerminatedNCT01276249
The STAPLE International Post-Market Registry
The STAPLE-International Post-Market Registry
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 108 (actual)
- Sponsor
- Medtronic Cardiovascular · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Aptus Endosystems STAPLE International Post-Market Registry is intended to expand the clinical knowledge base by including 'real world' subjects.
Detailed description
The Aptus Endosystems STAPLE International Post-Market Registry is intended to expand the clinical knowledge base by including 'real world' subjects. All subjects diagnosed with a qualifying AAA suitable for elective endovascular repair, who meet the inclusion/exclusion criteria for the registry, are eligible for enrollment and should be offered informed consent to participate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Fortevo Endograft | The Fortevo Endograft, Main Body and Iliac Lumen Delivery System are indicated for the endovascular treatments of patients with infrarenal abdominal aortic aneurysms or aortic-iliac aneurysms having suitable morphology for endovascular repair. |
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2015-04-01
- Completion
- 2015-06-19
- First posted
- 2011-01-13
- Last updated
- 2021-11-02
Locations
9 sites across 6 countries: Canada, Germany, Greece, Italy, Netherlands, Spain
Source: ClinicalTrials.gov record NCT01276249. Inclusion in this directory is not an endorsement.